NCT00001968View on ClinicalTrials.gov

Once-Daily Drug Regimen for HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2000

Study Completion Date

November 30, 2000

Conditions
Acquired Immunodeficiency SyndromeHIV Infections
Interventions
DRUG

Amprenavir

DRUG

Ritonavir

DRUG

Abacavir

DRUG

Lamivudine

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001968 - Once-Daily Drug Regimen for HIV-Infected Patients | Biotech Hunter | Biotech Hunter